Malignant Intestinal Neoplasm — Trials

Malignant Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,666
Recruiting: 939
Ph III recruiting: 109
Growth YoY: +12.2%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (772)

clinicaltrialsPublishedShowing 251–300 of 711 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07281157	Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer	recruiting	Phase 2	30	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Jun 3, 2026	clinicaltrials
NCT07622550	A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance	not yet recruiting	Phase 2	80	Jiangsu Cancer Institute & HospitalOTHER